Matthew Armstrong

Matthew Armstrong (he/him/his) joined the Department of Exercise Science in the Falk College of Sport and Human Dynamics in the Fall 2024 as an assistant professor. In August 2024, Armstrong founded the Applied Cardiovascular Physiology Lab at Syracuse University.

Prior to joining Syracuse University, Armstrong was a postdoctoral fellow in the Department of Health and Human Physiology from 2021-24 at the University of Iowa, where he conducted research focused on large artery structure and function. Before moving to the United States, he completed a Ph.D. in Australia at the Menzies Institute for Medical Research, University of Tasmania.

Armstrong’s research focuses on cardiovascular disease, particularly blood pressure and vascular dysfunction in health and disease. His work aims to understand the mechanisms of cardiovascular dysfunction and identify novel biomarkers for predicting adverse cardiovascular events. Using hemodynamic modeling approaches to investigate arterial dysfunction in humans has been the primary focus of his research and comprises the majority of his scholarly output.

Subsequent research exploring the effects of chemotherapy on large artery function among young cancer survivors has been supported by an Adolescent and Young Adult Research Award. Armstrong also has a funded pilot study investigating the application of deep learning models for the estimation of vascular age. In 2022, Armstrong was awarded the Journal of Human Hypertension’s Young Investigator Award.

Dr. Armstrong earned a Ph.D. in 2020 from the University of Tasmania, Australia, and a bachelor of science degree with honours in 2015 from Cardiff Metropolitan University, United Kingdom.